Bristol Myers Squibb today announced the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has recommended approval of Breyanzi® (lisocabtagene maraleucel; ...

Nintendo has finally revealed the Switch 2 with a video that confirms a number of new features while sparking burning questions for fans to discuss. While pre-announce leaks proved to be pretty ...

After many months, if not years, of leaks and speculation, it’s finally official: Nintendo has announced its next console, and it’s called Nintendo Switch 2. As the name implies, it’s a very ...

A Bangladeshi expatriate died three days after he was beaten for allegedly recording a video of an attack on a Chandpur union Chhatra League leader in Kapasia of Gazipur. The deceased, Enamul ...

BH3 mimetics are small molecules that mimic BH3-only proteins by binding to and inhibiting the prosurvival members of the Bcl-2 family ... (the majority with follicular lymphoma) received ...

He joined The Verge in 2019 after nearly two years at Techmeme. Nintendo shared the first details about the Nintendo Switch 2 in a video published Thursday. Nintendo doesn’t give a specific ...

The Switch 2 has been revealed, and it's coming this year. But Nintendo's not telling us more until April 2. For now, here's the trailer: Yes, there's a new Mario Kart. And yes, this looks a lot ...

Nintendo has unveiled the long-awaited successor to its popular Switch video game console: the Nintendo Switch 2. First-look images at the console design and a teaser trailer were revealed by ...

The Nintendo Switch 2 has been confirmed, and we'll find out more about it in a Nintendo Direct focused on the new console that's coming in early April. In a video released a few minutes ago ...

Sarepta’s flagship Duchenne muscular dystrophy drug Elevidys—which won FDA approval in June 2023—delivered preliminary fourth-quarter and full-year sales of $384.2 million and $820.8 million ...

The addition of Monjuvi to standard-of-care therapy reduced the risk of disease progression, relapse, or death in patients with relapsed/refractory follicular lymphoma Compared to placebo, the ...

John Seymour, MBBS, FRACP, PhD, explains the mechanism of action of BCL-2 inhibitors like venetoclax. John Seymour, MBBS, FRACP, PhD, director of hematology at the Peter MacCallum Cancer Center and ...